Altre lingue Athersys, Inc.

Azioni

ATHXQ

US04744L2051

Mercato chiuso - OTC Markets Altri mercati azionari 21:58:40 22/04/2024			Variaz. 5gg	Var. 1 gen.
0,0047 ^USD	+4,44%		+6,82%	-76,50%

05/04	Athersys, Inc. annuncia cambiamenti nel Consiglio di Amministrazione	CI
03/04	Healios K.K. (TSE:4593) ha completato l'acquisizione di sostanzialmente tutte le attività di Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA e ReGenesys, LLC.	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	11/04
Athersys : Acquisition/Asset Disposal - Form 8-K	05/04
Athersys, Inc. Announces Board Changes	05/04
Healios Concludes Purchase of Athersys Assets, Becoming Sole Owner of MultiStem IP	04/04
North American Morning Briefing : Focus Turns to -2-	04/04
Healios K.K. completed the acquisition of Substantially all assets of Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC .	03/04
Final DIP Financing Approved for Athersys, Inc.	13/02
Bidding Procedure Approved for Athersys, Inc.	13/02
Healios' Ischemic Stroke Trial Data Published in JAMA Neurology Journal	18/01
Interim DIP Financing Approved for Athersys, Inc.	12/01
Motion for Joint Administration Approved for Athersys, Inc.	12/01
Healios Steps In as Primary Bidder and Lender for Athersys’s Asset Sale Amidst Bankruptcy	10/01
Motion for Asset Sale Filed by Athersys, Inc.	06/01
Motion for Joint Administration Filed by Athersys, Inc.	06/01
Athersys, Inc. Filed for Bankruptcy	05/01
Healios K.K. entered into an asset purchase agreement to acquire Substantially all assets of ABT Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC for $2.8 million.	05/01
Athersys, Inc. Announces Termination of Maia Hansen as Chief Operating Officer, Effective from December 31, 2023	22/12
Athersys, Inc. Announces Termination of Daniel A. Camardo as Chief Executive Officer, Effective from December 31, 2023	22/12
Athersys Reports Third Quarter 2023 Financial Results and Business Highlights	17/11
Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives	17/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Athersys, Inc.

Azioni

ATHXQ

US04744L2051

Altre lingue

Filtri